The FDA provided an update on a potential treatment called convalescent plasma and is encouraging individuals who have recovered from COVID-19 to donate plasma to help others fight this disease. This plasma is an antibody-rich product made from blood donated by patients who have recovered from the disease caused by the virus. The agency also launched a new webpage to guide recovered COVID-19 patients to local blood or plasma collection centers to discuss their eligibility and potentially schedule an appointment to donate.
The update can be obtained at https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-encourages-recovered-patients-donate-plasma-development-blood?utm_campaign=041620_PR_Coronavirus%20%28COVID-19%29%20Update%3A%20Daily%20Roundup%20April%2016%2C%202020&utm_medium=email&utm_source=Eloqua and the webpage can be obtained at https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/donate-covid-19-plasma?utm_campaign=041620_PR_Coronavirus%20%28COVID-19%29%20Update%3A%20Daily%20Roundup%20April%2016%2C%202020&utm_medium=email&utm_source=Eloqua.